These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1506887

  • 1. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC, Baba T, Black KL.
    J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
    [Abstract] [Full Text] [Related]

  • 2. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
    Black KL, King WA, Ikezaki K.
    J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
    [Abstract] [Full Text] [Related]

  • 3. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T, Black KL, Ikezaki K, Chen KN, Becker DP.
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
    [Abstract] [Full Text] [Related]

  • 4. Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4.
    Black KL, King WA, Ikezaki K.
    Acta Neurochir Suppl (Wien); 1990 Jul; 51():140-1. PubMed ID: 1982476
    [Abstract] [Full Text] [Related]

  • 5. Enzymatic barrier protects brain capillaries from leukotriene C4.
    Black KL, Baba T, Pardridge WM.
    J Neurosurg; 1994 Nov; 81(5):745-51. PubMed ID: 7931622
    [Abstract] [Full Text] [Related]

  • 6. Increased opening of blood-tumour barrier by leukotriene C4 is dependent on size of molecules.
    Black KL, Chio CC.
    Neurol Res; 1992 Dec; 14(5):402-4. PubMed ID: 1282688
    [Abstract] [Full Text] [Related]

  • 7. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T, Nomura T, Bartus RT, Black KL.
    J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
    [Abstract] [Full Text] [Related]

  • 8. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
    Liu Y, Hashizume K, Samoto K, Sugita M, Ningaraj N, Asotra K, Black KL.
    Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
    [Abstract] [Full Text] [Related]

  • 9. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
    Inamura T, Black KL.
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
    [Abstract] [Full Text] [Related]

  • 10. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL.
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [Abstract] [Full Text] [Related]

  • 11. The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors.
    Baba T, Chio CC, Black KL.
    J Neurosurg; 1992 Sep; 77(3):403-6. PubMed ID: 1354721
    [Abstract] [Full Text] [Related]

  • 12. Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma.
    Inamura T, Nomura T, Ikezaki K, Fukui M, Pöllinger G, Black KL.
    Neurol Res; 1994 Apr; 16(2):125-8. PubMed ID: 7913997
    [Abstract] [Full Text] [Related]

  • 13. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR.
    Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
    [Abstract] [Full Text] [Related]

  • 14. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A, Walbridge S, Pluta RM, Saavedra JE, Keefer LK, Oldfield EH.
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 16. Evidence against leukotrienes as mediators of brain edema.
    Unterberg A, Schmidt W, Wahl M, Ellis EF, Marmarou A, Baethmann A.
    J Neurosurg; 1991 May 01; 74(5):773-80. PubMed ID: 2013778
    [Abstract] [Full Text] [Related]

  • 17. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
    Nomura T, Inamura T, Black KL.
    Brain Res; 1994 Oct 03; 659(1-2):62-6. PubMed ID: 7529648
    [Abstract] [Full Text] [Related]

  • 18. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats.
    Black KL, Hoff JT.
    Ann Neurol; 1985 Sep 03; 18(3):349-51. PubMed ID: 2996417
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
    Sugita M, Hunt GE, Liu Y, Black KL.
    Neurol Res; 1998 Sep 03; 20(6):559-63. PubMed ID: 9713849
    [Abstract] [Full Text] [Related]

  • 20. Metabolism and cardiovascular effects of leukotrienes in the marine toad Bufo marinus.
    Herman CA, Goss DD, Charlton GA, Pfeifer CA.
    Gen Comp Endocrinol; 1993 Oct 03; 92(1):113-22. PubMed ID: 8262353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.